Table 5.
Estimated (RT-PCR) viral load values during the treatment days.
| Treatments | ||||
|---|---|---|---|---|
| Overall | N | FNC, N = 911 | Placebo, N = 881 | p-value2 |
| Viral load (D1) | 178 | 10,398 (1,000; 11,613) [7,227] | 10,456 (1,019; 11,324) [8,178] | 0.635 |
| Viral load (D3) | 172 | 10,080 (533; 11,752) [6,730] | 10,199 (546; 11,434) [7,394] | 0.346 |
| Viral load (D5) | 166 | 101 (0; 10,219) [3,961] | 970 (2; 10,199) [4,175] | 0.331 |
| Viral load (D7) | 129 | 0 (0; 1,004) [2,335] | 10 (0; 9,828) [3,173] | 0.672 |
| Viral load (D9) | 97 | 5 (0; 1,010) [2,337] | 10 (0; 1,026) [2,626] | 0.120 |
| Viral load (D11) | 72 | 0 (0; 78) [1,146] | 10 (0; 102) [1,677] | 0.069 |
| Viral load (D13) | 50 | 0 (0; 102) [1,095] | 0 (0; 0) [702] | 0.655 |
| CTs (D1) | 178 | 0 (0; 0) [545] | 0 (0; 0) [439] | 0.686 |
| CTs (D3) | 172 | 24.2 (21.3; 27.0) [23.9] | 23.9 (21.6; 26.6) [23.9] | 0.299 |
| CTs (D5) | 166 | 24.7 (20.7; 28.1) [24.5] | 24.8 (21.5; 27.8) [24.3] | 0.334 |
| CTs (D7) | 129 | 28.8 (24.6; 31.0) [27.3] | 27.9 (24.5; 30.9) [26.7] | 0.685 |
| CTs (D9) | 97 | 31.00 (29.30; 31.00) [29.72] | 30.40 (28.60; 31.00) [28.99] | 0.119 |
| CTs (D11) | 72 | 31.00 (28.45; 31.00) [29.48] | 31.00 (31.00; 31.00) [29.90] | 0.062 |
| CTs (D13) | 50 | 31.00 (31.00; 31.00) [30.28] | 31.00 (31.00; 31.00) [30.43] | 0.655 |
1Median (25%; 75%) [Mean].
2Wilcoxon rank sum test.